|
 PH&T is an Italian pharmaceutical company engaged in research, development and production of generic drugs for specialist therapies and innovative medical devices, sold worldwide through licensees and distributors.
The company was founded in Milan in 1991 with the aim of selecting and developing niche products and selling them through firm commercial partnerships. In 2011 we are celebrating 20 years of activity.
PH&T specializes in difficult to formulate prescription products and has a consolidated experience in oral slow release, eye drop, nasal spray and injectable forms. Our offer allows generic companies to complement their product portfolio with difficult-to-formulate, not top-selling pharmaceuticals.
|
|
 PH&T and ISU Abxis announce their agreement for Zoledronic Acid in South Korea
April 2012 PH&T is proud to announce the successful agreement for the exclusive commercialization in South Korea of Zoledronic acid 4 mg./5 ml solution for infusion with the Company ISU Abxis Co.
|
|
Read more...
|
Epoprostenol PH&T successfully launched in Italy and the Netherlands.
October 2011 The launch of Epoprostenol PH&T has been successfully accomplished by Ibisqus in Italy and Devrimed in Netherlands.
|
|
Read more...
|
|
Forest Laboratories Receives European Marketing Approval for Colobreathe® (colistimethate sodium) with Turbospin® Dry Powder Inhaler.
|
|
Read more...
|
PH&T and GENETEC announce their agreement for Zoledronic Acid in Pakistan
January 2012 PH&T is proud to announce the successful agreement for the exclusive commercialization in Pakistan of Zoledronic acid 4 mg./5 ml solution for infusion with the Company GENETEC (PRIVATE) LIMITED Karachi Pakistan
|
|
Read more...
|
|
|
